143 related articles for article (PubMed ID: 35723749)
1. Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes.
Balakrishnan K; Ganesan K
Med Oncol; 2022 Jun; 39(9):132. PubMed ID: 35723749
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.
Balakrishnan K; Ganesan K
Funct Integr Genomics; 2020 Nov; 20(6):813-824. PubMed ID: 32949316
[TBL] [Abstract][Full Text] [Related]
3. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics.
Pandian J; Ganesan K
Exp Cell Res; 2022 Jan; 410(1):112956. PubMed ID: 34864005
[TBL] [Abstract][Full Text] [Related]
4. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional coexpression network reveals the involvement of varying stem cell features with different dysregulations in different gastric cancer subtypes.
Kalamohan K; Periasamy J; Bhaskar Rao D; Barnabas GD; Ponnaiyan S; Ganesan K
Mol Oncol; 2014 Oct; 8(7):1306-25. PubMed ID: 24917244
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma stage: an almost loss of fatty acid metabolism and gain of glucose metabolic pathways dysregulation.
Balakrishnan K
Med Oncol; 2022 Oct; 39(12):247. PubMed ID: 36209296
[TBL] [Abstract][Full Text] [Related]
7. YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates.
Bhaskar Rao D; Panneerpandian P; Balakrishnan K; Ganesan K
J Cell Commun Signal; 2021 Jun; 15(2):251-267. PubMed ID: 33620645
[TBL] [Abstract][Full Text] [Related]
8. Gastric Cancer Cell Lines Have Different
Maués JHDS; Ribeiro HF; Pinto GR; Lopes LO; Lamarão LM; Pessoa CMF; Moreira-Nunes CFA; de Carvalho RM; Assumpção PP; Rey JA; Burbano RMR
Can J Gastroenterol Hepatol; 2018; 2018():5804376. PubMed ID: 30410872
[No Abstract] [Full Text] [Related]
9. Identification of kinases and kinase inhibitors for the differential targeting of Wnt/β-catenin signaling in gastric cancer subtypes.
Bhaskar Rao D; Devanandan HJ; Ganesan K
Drug Dev Res; 2021 Dec; 82(8):1182-1192. PubMed ID: 34002415
[TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
[TBL] [Abstract][Full Text] [Related]
11. MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.
McNew KL; Whipple WJ; Mehta AK; Grant TJ; Ray L; Kenny C; Singh A
Mol Cancer Res; 2016 Dec; 14(12):1204-1216. PubMed ID: 27655129
[TBL] [Abstract][Full Text] [Related]
12. Abacavir induces the transcriptional activity of YY1 and other oncogenic transcription factors in gastric cancer cells.
Panneerpandian P; Devanandan HJ; Marimuthu A; Karthikeyan C; Ganesan K
Antiviral Res; 2020 Feb; 174():104695. PubMed ID: 31846633
[TBL] [Abstract][Full Text] [Related]
13. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
14. Identifying heterogeneous subtypes of gastric cancer and subtype‑specific subpaths of microRNA‑target pathways.
Li Y; Bai W; Zhang X
Mol Med Rep; 2018 Mar; 17(3):3583-3590. PubMed ID: 29286091
[TBL] [Abstract][Full Text] [Related]
15. A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors.
Fukamachi H; Kim SK; Koh J; Lee HS; Sasaki Y; Yamashita K; Nishikawaji T; Shimada S; Akiyama Y; Byeon SJ; Bae DH; Okuno K; Nakagawa M; Tanioka T; Inokuchi M; Kawachi H; Tsuchiya K; Kojima K; Tokino T; Eishi Y; Kim YS; Kim WH; Yuasa Y; Tanaka S
J Exp Clin Cancer Res; 2019 Mar; 38(1):127. PubMed ID: 30866995
[TBL] [Abstract][Full Text] [Related]
16. Identification of the targeted therapeutic potential of doxycycline for a subset of gastric cancer patients.
Pandian J; Panneerpandian P; Devanandan HJ; Sekar BT; Balakrishnan K; Selvarasu K; Muthupandi K; Ganesan K
Ann N Y Acad Sci; 2020 May; 1467(1):94-111. PubMed ID: 31944316
[TBL] [Abstract][Full Text] [Related]
17. Upregulated, 7q21-22 amplicon candidate gene SHFM1 confers oncogenic advantage by suppressing p53 function in gastric cancer.
Tamilzhalagan S; Muthuswami M; Periasamy J; Lee MH; Rha SY; Tan P; Ganesan K
Cell Signal; 2015 Jun; 27(6):1075-86. PubMed ID: 25697906
[TBL] [Abstract][Full Text] [Related]
18. High expression of NEK2 promotes gastric cancer progression via activating AKT signaling.
Wan H; Xu L; Zhang H; Wu F; Zeng W; Li T
J Physiol Biochem; 2021 Feb; 77(1):25-34. PubMed ID: 33201407
[TBL] [Abstract][Full Text] [Related]
19. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
[TBL] [Abstract][Full Text] [Related]
20. Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Zhu Z; Qin J; Dong C; Yang J; Yang M; Tian J; Zhong X
Bioengineered; 2021 Dec; 12(1):4780-4793. PubMed ID: 34346836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
